AKTS

Conviction 100HealthcareScan · Thu, Jun 25, 2026

Shooting star

AKTS$31.09+8.33%

ResistanceSupportVol 14

Vol MA14 399.5K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Aktis Oncology, Inc.Biotechnologywww.aktisoncology.com ↗

Price31.09

Change+8.33%

Gap+6.10%

Rel volume2.34×

Avg volume333.22K

Avg $ vol7.83M

SMA 2021.97

SMA 5020.55

SMA 20011.38

Price vs 50+51.32%

Price vs 200+173.31%

MA stackbullish

50/200 cross—

Supertrendup · 24.92

RSI (14)81

MACD hist1.06

MACD crossbull · 8d

Stoch %K / %D84 / 92

ADX (14)30

+DI / −DI44 / 6

RSI divergence—

MACD divergence—

ATR %+6.63%

ADR %8.35%

52w high31.09

52w low0.0372

From 52w high+0.00%

Above 52w low+83475.27%

New 52w highYes

SqueezeOff

Bollinger width63.09%

%B1.16

Donchian pos84.20%

Donchian high33.50

Donchian low18.25

AVWAP (52w high)31.52

vs AVWAP high-1.35%

AVWAP (52w low)4.99

vs AVWAP low+522.63%

OBV trendUp

Chaikin MF (20)-0.04

Today vs 20d2.34×

Avg vol (14d)399.5K

Avg vol (20d)333.22K

Avg $ vol (20d)7.83M

Market cap1.66B

RS 3m (vs SPY)+41.80%

RS 6m (vs SPY)+28266.05%

RS line new highYes

Trend template—

Technical rank98.8

1 week+32.13%

1 month+51.07%

3 months+66.79%

6 months+31021.12%

1 year—

YTD+38.79%

P/E—

P/B3.28

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current19.49

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target36.33

Target upside16.85%

Analyst ratingBuy

Institutional64.98%

Ent. value1.29B

Revenue3.23M

Net income-18.32M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out53.4M

Employees79

ListedFri, Jan 9, 2026

Free float23M

Float %43.1%

Short interest2.67M

Days to cover18.4d

Short volume74.4%

Squeeze score83 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.38 vs −$0.31

Last surprise-22.6% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank98.8 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 16 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 12
1 scan
→
Breaking out now
Jun 15 – Jun 16
2 scans
→
Broke out
Jun 18 – Jun 22
2 scans

Congress activity

Disclosed STOCK Act trades in AKTS

All disclosures →

No recent disclosed trades by Congress in AKTS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AKTS · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Gormley Glenn Director · Stock Option (Right to Buy) · 2026-04-15	Grant	37.87K	$0	2026-04-15	2026-04-16

SEC filings

EDGAR filings in AKTS

EDGAR →

No recent SEC filings on file for AKTS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.